Research progress on the application of RPA-CRISPR/Cas12a in the rapid visual detection of pathogenic microorganisms

Tuo Ji1,2,3, Xin Fang4, Yuzhi Gao1,2,3

  • 1Lianyungang Clinical College, Bengbu Medical University and The Second People's Hospital of Lianyungang, Lianyungang, China.

Insights

Rapid pathogen detection is crucial due to emerging diseases and antibiotic resistance. The combination of Recombinase Polymerase Amplification (RPA) and CRISPR/Cas12a offers a sensitive, accurate, and simple method for identifying microorganisms.

Area of Science:

  • Microbiology
  • Molecular Biology
  • Biotechnology

Background:

  • Emerging novel pathogens and antibiotic resistance necessitate advanced detection methods.
  • Current technologies often lack the speed, sensitivity, or accessibility required for global public health challenges.

Purpose of the Study:

  • To provide a comprehensive overview of the Recombinase Polymerase Amplification (RPA) and CRISPR/Cas12a integrated system.
  • To highlight the research progress and potential applications of RPA-CRISPR/Cas12a in pathogen detection.

Main Methods:

  • Utilizes Recombinase Polymerase Amplification (RPA) for rapid, isothermal amplification of target gene fragments.
  • Employs CRISPR/Cas12a for precise recognition and cleavage of specific nucleic acid sequences.
  • Integrates RPA and CRISPR/Cas12a to enhance detection sensitivity and accuracy.

Main Results:

  • The RPA-CRISPR/Cas12a combination demonstrates enhanced sensitivity and accuracy in pathogen detection.
  • This integrated system simplifies operational procedures and reduces reliance on specialized equipment.
  • The technology shows significant potential for clinical diagnostics and point-of-care testing.

Conclusions:

  • RPA-CRISPR/Cas12a is a powerful tool for rapid and precise pathogen detection.
  • Its integration offers a promising solution for clinical medicine and public health surveillance.
  • Further optimization and application of this technology can bolster global health security.

Related Concept Videos

CRISPR01:59

CRISPR

Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced Short...
CRISPR and crRNAs02:53

CRISPR and crRNAs

Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
CRISPR01:59

CRISPR

Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced Short...
CRISPR/Cas9 Genome Editing01:28

CRISPR/Cas9 Genome Editing

The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...